explore -WSS

explore

author：focus 2025-09-07 17:29:12 - browse：467

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： What should King Charles tell the public about his cancer?

WSS

UnitedHealth wins $3.3 billion takeover of Amedisys

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

The simple reason for the increase in autism diagnosis

BioAge raises $170M for combination therapy with Zepbound

For Medicare Advantage, Democrats want stronger protections around AI

Belarusian journalist sentenced to 4 years in prison as crackdown continues

leisure time

explore

leisure time

In Memoriam: Notable people who died in 2023

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

The cancer drug shortage isn’t new — and neither are the solutions

Medical experts exlpore how to eliminate bias in clinical algorithms

Alkermes shareholders re

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

focus

'Revelatory' study finds a smoking impact that remains after quitting

Tuskegee Airman Raymond Cassagnol dies at 102

To avoid data mishandling cases, universities eye AI and other tools

What we’ve learned from the Aduhelm mess

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Gilead might be held responsible for not developing a drug

hotspot

explore

Wikipedia

focus